Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: current status and future prospects

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: current status and future prospects

Visceral leishmaniasis (VL) is a vector-borne chronic infectious disease caused by the protozoan parasite Leishmania donovani or Leishmania infantum. VL is a serious public health problem, causing high morbidity and mortality in the developing world with an estimated 0.2 -0.4 million new cases each...

Full description

Bibliographic Details
Main Authors: Om Prakash eSingh, Shyam eSundar
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-06-01
Series:Frontiers in Immunology
Subjects:
Immunotherapy
Visceral leishmaniasis
IL-10
Treatment
Resistance
anti-IL-10 mAb
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00296/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00296/full

Similar Items